Membrane protein mediation of thromboxane A2-induced platelet aggregation.
作者信息
Kao K J, Hagen P O, Pizzo S V
出版信息
Biochem Biophys Res Commun. 1980 Nov 17;97(1):87-93. doi: 10.1016/s0006-291x(80)80138-0.
PMID:6779820
Abstract
摘要
相似文献
1
Membrane protein mediation of thromboxane A2-induced platelet aggregation.血栓素A2诱导血小板聚集的膜蛋白介导作用。
Biochem Biophys Res Commun. 1980 Nov 17;97(1):87-93. doi: 10.1016/s0006-291x(80)80138-0.
2
Modulation of human platelet function by prostacyclin and thromboxane A2.前列环素和血栓素A2对人血小板功能的调节
Fed Proc. 1979 Jan;38(1):83-8.
3
Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.完整血小板中血栓素A2/前列腺素H2及ADP诱导的钙释放的逆转
Am J Physiol. 1985 Jul;249(1 Pt 2):H8-13. doi: 10.1152/ajpheart.1985.249.1.H8.
4
Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
Adv Prostaglandin Thromboxane Res. 1980;6:493-6.
5
6
Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.血栓素A2/前列腺素H2可动员人血小板中的钙。
Am J Physiol. 1985 Jul;249(1 Pt 2):H1-7. doi: 10.1152/ajpheart.1985.249.1.H1.
7
Effects of etamsylate on platelet functions and arachidonic acid metabolism.酚磺乙胺对血小板功能及花生四烯酸代谢的影响。
Thromb Haemost. 1982 Dec 27;48(3):330-3.
8
Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.蒎烷血栓素A2：一种具有抗血栓特性的血栓素A2拮抗剂。
Adv Prostaglandin Thromboxane Res. 1980;6:489-92.
9
Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.血栓烷诱导人血小板中磷脂酸的形成。与受体占据及胞质游离钙变化的关系。
Biochem J. 1984 May 1;219(3):833-42. doi: 10.1042/bj2190833.
10
Abnormal platelet response to thromboxane A2.血小板对血栓素A2的异常反应。
J Clin Invest. 1981 Jun;67(6):1801-4. doi: 10.1172/jci110221.
引用本文的文献
1
Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates.抗血小板治疗可减少非人灵长类动物中小直径血管假体（聚四氟乙烯）远端的主动脉内膜增生。
Ann Surg. 1982 Mar;195(3):328-39. doi: 10.1097/00000658-198203000-00014.
Zotero 插件